Evotec and Celgene Enter into Strategic Oncology Partnership

LEVERAGING EVOTEC'S PHENOTYPIC SCREENING CAPABILITIES AND COMPOUND LIBRARIES WITH AN INITIAL FOCUS ON SOLID TUMOURS UPFRONT PAYMENT OF $ 65 M SIGNIFICANT MILESTONE PAYMENTS AND TIE…
Read the full story: Bioportfolio Latest News